Country: United Kingdom
Language: English
Source: VMD (Veterinary Medicines Directorate)
Sodium Calciumedetate
Animalcare Ltd
QV03AB03
Sodium Calciumedetate
Solution for injection
POM-V - Prescription Only Medicine – Veterinarian
Cattle, Dogs
Mineral anti-toxic
Expired
1995-01-13
Revised: June 2013 AN: 00242/2013 Page 1 of 4 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Sodium Calciumedetate 250mg/ml Concentrate for Solution for Injection 2. QUALITATIVE AND QUANTITATIVE COMPOSITION ACTIVE SUBSTANCE(S) Sodium Calciumedetate EXCIPIENTS For a full list of excipients, see section 6.1 250 mg/ml 3. PHARMACEUTICAL FORM Concentrate for solution for injection. A clear, colourless solution. 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Cattle and dogs 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES In the treatment of lead poisoning for cattle and dogs. 4.3 CONTRAINDICATIONS None. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES Dogs: Do not administer more than 2000mg per day. 4.5 SPECIAL PRECAUTIONS FOR USE i. Special precautions for use in animals Ensure the animal has unrestricted access to non-contaminated drinking water. Other antidotes may be employed and supportive measures may be required. The source of lead poisoning should be identified and removed from the animal’s environment. Revised: June 2013 AN: 00242/2013 Page 2 of 4 ii. Special precautions for the person administering the veterinary medicinal product to animals If accidentally injected to humans, obtain medical help promptly and show the doctor this warning. Advice to doctor As excretion is predominantly renal, an adequate urinary flow must be established and maintained. Monitoring of proteinuria and haematuria, and of renal function is advisable. Monitoring of zinc levels may also be required as Sodium Calciumedetate can chelate with several endogenous metals. Wash hands after use. iii. Other precautions None 4.6 ADVERSE REACTIONS (FREQUENCY AND SERIOUSNESS) The kidneys of animals with high lead burdens may become overloaded when Sodium Calciumedetate is given, especially if the chelator is administered too rapidly, with resulting adverse kidney reactions or occasional deaths. Overdosage may result in temporary nephroses. 4.7 USE DURING PREGNANCY, LACTATION OR LAY None 4.8 INTERACTION WITH OTHE Read the complete document